GMT CAPITAL CORP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
GMT CAPITAL CORP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,425,488
-1.9%
411,200
-4.8%
0.32%
-2.5%
Q2 2023$8,585,827
-1.0%
432,100
-14.6%
0.32%
-4.4%
Q1 2023$8,669,493
+19.3%
506,100
+36.3%
0.34%
+1.5%
Q4 2022$7,266,341
+22.6%
371,3000.0%0.34%
-9.0%
Q3 2022$5,926,000
-13.3%
371,300
-25.3%
0.37%
-15.4%
Q2 2022$6,836,000496,8000.44%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders